Vericel Corp. (VCEL)
39.90
-1.05
(-2.56%)
USD |
NASDAQ |
Aug 31, 16:00
39.89
-0.01
(-0.03%)
After-Hours: 20:00
Vericel Cash from Operations (TTM) : 69.67M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 69.67M |
| March 31, 2026 | 61.69M |
| December 31, 2025 | 51.91M |
| September 30, 2025 | 59.14M |
| June 30, 2025 | 47.24M |
| March 31, 2025 | 57.56M |
| December 31, 2024 | 58.16M |
| September 30, 2024 | 46.01M |
| June 30, 2024 | 42.99M |
| March 31, 2024 | 34.65M |
| December 31, 2023 | 35.31M |
| September 30, 2023 | 32.20M |
| June 30, 2023 | 28.06M |
| March 31, 2023 | 21.00M |
| December 31, 2022 | 16.61M |
| September 30, 2022 | 20.19M |
| June 30, 2022 | 20.80M |
| March 31, 2022 | 22.42M |
| December 31, 2021 | 29.04M |
| September 30, 2021 | 29.83M |
| June 30, 2021 | 30.76M |
| March 31, 2021 | 22.97M |
| December 31, 2020 | 17.57M |
| September 30, 2020 | 9.385M |
| June 30, 2020 | 12.71M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.651M |
| December 31, 2019 | -7.183M |
| September 30, 2019 | -7.722M |
| June 30, 2019 | -13.60M |
| March 31, 2019 | -0.663M |
| December 31, 2018 | -0.412M |
| September 30, 2018 | -2.189M |
| June 30, 2018 | -9.443M |
| March 31, 2018 | -9.656M |
| December 31, 2017 | -13.18M |
| September 30, 2017 | -23.32M |
| June 30, 2017 | -22.27M |
| March 31, 2017 | -21.74M |
| December 31, 2016 | -19.89M |
| September 30, 2016 | -14.62M |
| June 30, 2016 | -11.16M |
| March 31, 2016 | -10.50M |
| December 31, 2015 | -13.35M |
| September 30, 2015 | -15.55M |
| June 30, 2015 | -23.26M |
| March 31, 2015 | -24.85M |
| December 31, 2014 | -25.41M |
| September 30, 2014 | -23.51M |
| June 30, 2014 | -19.22M |
| March 31, 2014 | -17.86M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| AbbVie, Inc. | 19.51B |
| ADMA Biologics, Inc. | 136.72M |
| Kyntra Bio, Inc. | -38.05M |
| Conexeu Sciences, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 160.32M |